Page last updated: 2024-12-06
n,n'-diacetylhydrazine
N,N'-Diacetylhydrazine, also known as 1,2-diacetylhydrazine, is a white crystalline solid that is commonly used as a precursor in the synthesis of various chemical compounds. Its synthesis involves the reaction of hydrazine with acetic anhydride. The compound exhibits interesting biological activities, such as antitumor and anti-inflammatory effects, making it a subject of extensive research in the field of medicinal chemistry. Its potential applications in pharmaceuticals and agrochemicals are also being explored. The molecule's ability to form metal complexes has garnered attention in the field of coordination chemistry, leading to studies on its complexation behavior with different metal ions.'
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 72884 |
| CHEMBL ID | 3091852 |
| CHEBI ID | 80616 |
| SCHEMBL ID | 606948 |
| SCHEMBL ID | 23224226 |
| MeSH ID | M0124787 |
Synonyms (45)
| Synonym |
|---|
| 1.2-diacetylhydrazine |
| acetic acid, 2-acetylhydrazide |
| nsc 42939 |
| hydrazine,2-diacetyl- |
| nsc42939 |
| 1,2-diacetylhydrazine |
| nsc-42939 |
| n,n'-diacetylhydrazine |
| diacetyl hydrazine |
| einecs 221-576-1 |
| sym-diacetylhydrazine |
| diacetylahydrazine |
| hydrazine, 1,2-diacetyl- |
| diacetylhydrazine |
| n'-acetylacetohydrazide |
| 3148-73-0 |
| 1,2-diacetylhydrazine, 98% |
| D2796 |
| NCGC00248525-01 |
| n'-acetyl-acetic acid hydrazide |
| NCGC00257653-01 |
| dtxsid7020390 , |
| cas-3148-73-0 |
| dtxcid10390 |
| tox21_200099 |
| A820875 |
| unii-ymr3zf0q4m |
| ymr3zf0q4m , |
| ec 221-576-1 |
| FT-0606330 |
| AKOS015900792 |
| SCHEMBL606948 |
| CHEMBL3091852 |
| chebi:80616 , |
| diacetylhydrazide |
| n'-acetylacetohydrazide # |
| mfcd00008673 |
| AS-57968 |
| J-018442 |
| Q27149664 |
| D87230 |
| SCHEMBL23224226 |
| SB86069 |
| n,n inverted exclamation mark -diacetylhydrazine |
| SY048493 |
Research Excerpts
Pharmacokinetics
Drug Classes (1)
| Class | Description |
|---|
| carbohydrazide | A hydrazide consisting of hydrazine carrying one or more carboacyl groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.19
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.19 (24.57) | | Research Supply Index | 2.40 (2.92) | | Research Growth Index | 4.59 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |